FlandersBio offers an up-to-date life sciences database with detailed information about all FlandersBio members.
FlandersBio beschikt over een geüpdate life sciences databank met een gedetailleerd overzicht van alle FlandersBio-ledenbedrijven.
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With 9000 people in approximately 40 countries, the company generated revenue of EUR 3.4 billion in 2012. UCB is listed on Euronext Brussels (symbol: UCB).
With a unique combination of expertise in biology and chemistry, UCB is a global biopharma focusing on providing solutions for patients living with severe diseases in two therapeutic areas - CNS and Immunology.
UCB is an R&D driven company, investing approximately 20% of sales in R&D every year. Research is the lifeblood of UCB's future and is vital to the organisation.
The strength of our science and technologies is based on
Fundamental to our philosophy is connecting science in new ways, notably chemistry and biology, to leverage the potential of these two disciplines.